UPDATE – Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
Regeneron Pharmaceuticals Inc REGN
$698.25
▼ -2.05%
($-14.62)
Index member:
S&P 500
NASDAQ-100
Open
$712.69
Prev Close
$712.87
Day Range
$693.70 – $717.89
52W Range
$476.49 – $821.11
Market Cap
$75.84B
P/E (TTM)
16.70
Beta
0.29
Div Yield
0.53%
EPS (TTM)
$41.03
📋 Company Profile
| Industry | Biotechnology |
| Sector | Health Care |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 1991-04-02 |
| Shares Out. | 105,720,000 |
| Website | regeneron.com/ ↗ |
| Phone | 17813705000 |
Regeneron Pharmaceuticals Inc is a publicly traded company under the ticker symbol REGN on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
38 analysts (2026-05-01)
📰 Latest News for REGN
Next Generation of Scientific Leaders Awarded More Than $7 Million at the 2026 Regeneron International Science and Engineering Fair
Transcript : Regeneron Pharmaceuticals, Inc. Presents at Bank of America Global Healthcare Conference 2026, May-12-2026 10
Regeneron Pharmaceuticals, Inc. (REGN) Presents at Bank of America Global Healthcare Conference 2026 Transcript
NTLA Q1 Earnings Beat Estimates, Revenues Miss Mark, Pipeline in Focus
Is Regeneron Pharmaceuticals (REGN) Among the Best Biotech Stocks to Invest In According to Billionaire Steve Cohen?
Dr. Scott Gottlieb: Could see more hantavirus case, but don't think it will get out of control
Regeneron’s Otarmeni Win Links Gene Therapy Ambition With ESG Commitments